Fe Single-Atom Carbon Dots Nanozyme Collaborated with Nucleic Acid Exonuclease III-Driven DNA Walker Cascade Amplification Strategy for Circulating Tumor DNA Detection

• Published in: Analytical chemistry (Washington) Vol. 96; no. 12; pp. 4774 - 4782
• Main Authors: Long, Yanyi, Zhao, Jiaying, Ma, Wanting, He, Congjuan, Pei, Wen, Hou, Jingzhou, Hou, Changjun, Huo, Danqun
• Format: Journal Article
• Language: English
• Published: United States American Chemical Society 26.03.2024
• Subjects: Amplification; Biosensing Techniques - methods; Biosensors; Cancer; Carbon; Carbon dots; Catalysts; Circulating Tumor DNA; Deoxyribonucleic acid; Detection; Detection limits; DNA; Electrical conductivity; Electrical resistivity; Electrochemical Techniques - methods; Electrochemistry; Electrodes; Electron transfer; Exodeoxyribonucleases; Exonuclease; Glassy carbon; Gold - chemistry; Humans; Iron; Limit of Detection; Metal Nanoparticles - chemistry; Neoplasms; Nucleic Acids; Oxidation; Oxidoreductions; Sensors; Serum; Specificity; Tumor markers; Tumors
• ISSN: 0003-2700; 1520-6882; 1520-6882
• DOI: 10.1021/acs.analchem.3c04202

Circulating tumor DNA (ctDNA), as a next-generation tumor marker, enables early screening and monitoring of cancer through noninvasive testing. Exploring the development of new methods for ctDNA detection is an intriguing study. In this work, a unique electrochemical biosensor for the ctDNA detector was constructed in the first utilizing Fe single-atom nanozymes-carbon dots (SA Fe-CDs) as a signaling carrier in collaboration with a DNA walker cascade amplification strategy triggered by nucleic acid exonuclease III (Exo III). The electrochemical active surface area of AuNPs/rGO modified onto a glassy carbon electrode (AuNPs/rGO/GCE) was about 1.43 times that of a bare electrode (bare GCE), with good electrical conductivity alongside a high heterogeneous electron transfer rate (5.81 × 10–3 cm s–1), that is, as well as the ability to load more molecules. Sequentially, the DNA walker cascade amplification strategy driven by Exo III effectively converted the target ctDNA into an amplified biosignal, ensuring the sensitivity and specificity of ctDNA. Ultimately, the electrochemical signal was further amplified by introducing SA Fe-CDs nanozymes, which could serve as catalysts for 3,3′,5,5′-tetramethylbenzidine (TMB) oxidation with facile responding (V max = 0.854 × 10–6 M s–1) and robust annexation (K m = 0.0069 mM). The integration of the triple signal amplification approach achieved detection limits as low as 1.26 aM (S/N = 3) for a linearity spanning from 5 aM to 50 nM. In this regard, our proposal for a biosensor with exceptional assay properties in complicated serum environments had great potential for early and timely diagnosis of cancer.